LXEO

Lexeo Therapeutics, Inc. Common Stock (LXEO)

US
$ 2.710.74%

Price Chart

Key Statistics

Market Cap
$ 93.6M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
513.82K
52W High
$ 19.50
52W Low
$ 1.45
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
3.1102
200-Day MA
6.2622
52 Week High
19.5
52 Week Low
1.45

About LXEO

Lexeo Therapeutics, Inc., a clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Employees
75
Headquarters
New York, NY
CEO
Mr. R. Nolan Townsend

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
STM
STMicroelectronics ...
$ 28.47
10.95
U
Unity Software Inc....
$ 28.01
6.99
NIO
NIO Inc. American d...
$ 3.77
6.50
CHPT
ChargePoint Holding...
$ 0.83
6.41
RDDT
Reddit Inc. Class A...
$ 117.49
6.08

Top Losers

Symbol/Name
LTP
% Chg
UAVS
AgEagle Aerial Syst...
$ 1.06
-12.40
GPMT
Granite Point Mortg...
$ 2.57
-4.10
PEB
Pebblebrook Hotel T...
$ 8.80
-3.93
HP
Helmerich & Payne I...
$ 16.19
-3.92
VLO
Valero Energy Corpo...
$ 126.37
-3.50